908 Devices Inc.
NASDAQ:MASSMedical - Devices
+$0.22 today
- Market cap
- $395.86M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
Volume 0.25M
Average 0.27M
MASS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
908 Devices Inc.NASDAQ: MASS
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 14.7% from a year ago
Cash & equivalents stood at $67.56M at the end of Q1 FY2026, down 14.7% from a year earlier and down 4.2% from the prior quarter. Over 3 fiscal years it compounded at -15.7% a year.
Context
- Cash & equivalents amounted to 36.2% of total assets at the end of Q1 FY2026, down 4.2 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -14.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 112.97M USD
- Year-over-year change
- +156.6%
- 4-year CAGR
- -15.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 112.97M | +156.6% |
| FY2024 | 2024-12-31 | 44.03M | -63.6% |
| FY2023 | 2023-12-31 | 121.04M | -35.8% |
| FY2022 | 2022-12-31 | 188.42M | -15.9% |
| FY2021 | 2021-12-31 | 224.07M | — |
Cash & Equivalents vs competitors
How MASS compares with its peers on the latest reported figures
- MASS's Mar 2026 cash & equivalents of $67.56M is the lowest of the 3 companies compared; the peer median is $1.26B.
- Its year-over-year change of -14.7% is the lowest of 3, against a peer median of +9.6%.
- Cash & equivalents amounts to 36.2% of total assets for MASS, versus a peer median of 12.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $1.76B | +14.5% | +19.3% | 12.6% | |
| Jun 2026 | $768.5M | +4.7% | +4.7% | 13.0% | |
| Mar 2026 | $67.56M | -14.7% | -15.7% | 36.2% | |
| Peer median (excluding MASS) | $1.26B | +9.6% | +12.0% | 12.8% | |
Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 224.07M | 188.42M | 121.04M | 44.03M | 112.97M |
| Short-term Investments | 0 | 0 | 24.64M | 25.57M | 0 |
| Net Receivables | 16.58M | 10.03M | 8.99M | 12.63M | 11.33M |
| Inventory | 7.92M | 12.51M | 14.94M | 16.17M | 12.99M |
| Other Current Assets | 60K | 4.66M | 4.18M | 4.66M | 7.27M |
| Total Current Assets | 252.89M | 215.63M | 173.79M | 103.06M | 144.56M |
| Property, Plant & Equipment (Net) | 6.79M | 7.04M | 9.58M | 10.33M | 8.63M |
| Goodwill | 0 | 10.05M | 10.37M | 0 | 0 |
| Intangible Assets | 0 | 8.49M | 7.86M | 45.26M | 36.41M |
| Long-term Investments | 0 | 0 | 171K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.23M | 1.38M | 1.22M | 829K | 471K |
| Total Non-current Assets | 8.01M | 26.96M | 29.19M | 56.42M | 45.51M |
| Total Assets | 260.91M | 242.59M | 202.98M | 159.48M | 190.07M |
| Account Payables | 1.37M | 1.4M | 1.19M | 2.06M | 8.42M |
| Short-term Debt | 0 | 0 | 2.02M | 1.87M | 16.71M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 5.16M | 7.51M | 10.63M | 12.13M | 8.93M |
| Other Current Liabilities | 3.27M | 3.94M | 2.72M | 9.1M | 0 |
| Total Current Liabilities | 14.84M | 19.23M | 22.55M | 25.15M | 34.06M |
| Long-term Debt | 15M | 15M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 2.67M | 2.44M | 2.03M | 0 |
| Deferred Revenue (Non-current) | 0 | 11.5M | 8.57M | 10.68M | 8.33M |
| Other Non-current Liabilities | 11.96M | 555K | 0 | 2.28M | 3.98M |
| Total Non-current Liabilities | 31.47M | 32.76M | 14.94M | 19.74M | 12.31M |
| Total Liabilities | 46.3M | 51.99M | 37.49M | 44.88M | 46.37M |
| Common Stock | 31K | 32K | 33K | 35K | 36K |
| Retained Earnings | (100.64M) | (134.2M) | (170.6M) | (242.81M) | (223.32M) |
| Accumulated OCI | 0 | 798K | 1.37M | 1.15M | 54K |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 214.6M | 190.6M | 165.49M | 114.59M | 143.7M |
| Total Debt | 20.85M | 19.51M | 5.95M | 6.61M | 16.71M |
| Net Debt | (203.22M) | (168.91M) | (115.1M) | (37.43M) | (96.26M) |
908 Devices Inc.
NASDAQ:MASS
Intrinsic Alpha fair value
Locked
Current Price
$9.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.